Vetanic
Latest round
- Series B
Last raised
- Aug 2022
Total raised
- $5M
Investors
- 2
About Vetanic
Based in Tokyo, Japan, Vetanic Inc.Founded in 2021, Vetanic Inc. focuses on animal regenerative medicine.Vetanic specializes in animal regenerative medicine, focusing on the development and application of iPS cell technology. Their offerings include generating canine iPS cells and differentiating them into canine mesenchymal stem cells (MSCs) for regenerative medical products.Vetanic operates by commercializing regenerative medical products derived from their proprietary iPS cell technology. The company aims to introduce new regenerative medical products while expanding into wider markets beyond Japan as regulatory approvals are secured.
Who invested in Vetanic
2 investors across 2 rounds
See all investors in Vetanic
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vetanic
Who invested in Vetanic?
Vetanic has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vetanic raised?
Vetanic has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Vetanic last raise money?
Vetanic's most recent round on record is a Series B, in Aug 2022.
What does Vetanic do?
Based in Tokyo, Japan, Vetanic Inc.
Where is Vetanic headquartered?
Vetanic is headquartered in Tokyo, Japan.
Which VCs invest in companies like Vetanic?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Vetanic's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Vetanic? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.